The present invention relates to a biochip assembly comprising a plurality of enclosed elongate microchannels, each microchannel having an inlet port adjacent one of its proximal and distal ends, and an outlet port adjacent its other end; a plurality of reservoir wells for use with the microchannels; an enclosed liquid delivery channel assembly having two or more combined inlet and outlet ports, at least one forming an inlet port and at least one other forming an outlet port; and an enclosed sample holder transfer assembly for connecting a port of one module to a port or reservoir well of another module and for connecting two reservoir wells together.
Various biochip assemblies and, in particular, methods for using such biochip assemblies have been previously described in our co-pending PCT Patent Application Nos. IE02/00107 (WO 03/060056) and No. 02/00060 (WO 02/090771) and European Patent Specification Nos. EP 1252929 and EP 1221617. The disclosure of all these patent specifications is included herewith by way of reference. In these specifications, various biochip assemblies are described, together with various assays that may be carried out using such biochips. In particular, these specifications describe various biological assays and, in particular, various configurations of microchannels that may be used in such biochips.
It may be stated, with a fair deal of certainty, that microfluidics, namely the science of handling minute volumes of liquid, has promised to and undoubtedly will revolutionise the way many researchers execute testing procedures in a laboratory of various disciplines, whether it be chemistry or biology. Microfluidic devices offer significant potential advantages over current use instrumentation, particularly in terms of savings in costs and, often more importantly, in both sample and reagent consumption.
Microfluidics can be employed within the area of cell based assays in order to mimic the continuous flow regime of microcapillaries, as has been described in the above-referenced patent specifications.
In this specification, the term “biochip”, is used to relate to a microfluidic device in which the sample of reagent liquid is transported along the device in order to perform an experiment. For this, the device must have an appropriate network of microchannels. This definition falls under the assembly of paradigms called “Laboratory on a Chip”. This should be distinguished from a DNA or protein biochip. The latter are based on a completely different technology in which an assembly of DNA fragments or proteins are statically spotted on a substrate. They are described confusingly by the same word “biochip” (or DNA/protein biochip).
There are various problems at the present moment with biochips, principally arising from the fact that they are relatively complex devices designed by individuals for specific experiments, rather than being universal in use. They are thus essentially specific biochip assemblies, designed and manufactured for a specific requirement, rather than more universal use. Additionally, the robustness of biochip assemblies needs to be improved. Effectively, this means that the construction of the biochip assemblies needs to be simplified.
A further problem with the present construction of biochip assemblies is that they are not easy to integrate with the normal equipment available in laboratories. The user is too often restricted to purchasing an expensive controller for each kind of biochip developed by a particular individual or company. It is essential that such biochip assemblies be usable with a wide range of inter alia optical readers, MALDI mass spectrometers, DNA sequencers and other common laboratory equipment.
A further problem with current biochip assemblies relates to the transfer of samples to and from the various parts of the biochip assembly. Ideally, the biochip should be capable of operating with conventional manual and automated devices for sample transfer (usually called pipettors).
Finally, it is essential that the cost of the biochip assembly be reduced and in particular, that the biochip assembly have reduced maintenance or operating costs in the sense that each experiment or test does not lead to considerable expenditure in relation to the biochip assembly.
According to the invention, there is provided a biochip assembly comprising:
The advantage of this is that by having removable biochip modules, it only becomes necessary to dispose of those modules that are contaminated during a particular experiment. In many instances, it is advantageous to dispose of the microchannel containing module. Generally, particular modules and components may be removed for cleaning and re-use. Further, any module may be removed for cleaning and re-use. It also allows test specific modules to be used.
In one embodiment of the invention, the transfer conduits are of a flexible material.
In another embodiment, there are two reservoir containing modules.
Preferably, a reservoir containing module is arranged on either side of the microchannel containing module with the input module adjacent one of the reservoir containing modules. This allows for easy transfer of reagent and sample.
In another embodiment of the invention, releasable connection means are provided on the main support frame for securing each of the support plates in spaced-apart relationship with each of the input module and the microchannel containing module and with each rigid tube connecting in liquid sealing manner with the appropriate port. The advantage of this is that there would be no liquid escape or the ingress of air.
In one embodiment of the invention, each port comprises a compressible seal for engagement with a rigid tube.
In another embodiment, the releasable connection means is adapted to engage the rigid tube with the compressible seal to form a liquid seal. This ensures adequate sealing against air ingress and liquid leaking.
In another embodiment of the invention, the cross-sectional area of the microchannel varies along its length. The advantage of this is that one can now carry out experiments using the biochip for situations, for example, where capillaries or other portions of a patient's body might be constricted in some way. For example, blocking of arteries and the like, could be easily studied.
In another embodiment of the invention, the microchannel containing module comprises:
This is a particularly easy way of manufacturing a microchannel. It will also allow any shape of microchannel to be manufactured easily.
In one embodiment of the invention, the intermediate layer is of a photo-resist fluoro-polymer material, secured to the other layers by ultraviolet (UV) curing. This is a particularly easy way of manufacturing the microchannel containing module.
In another embodiment of the invention, the intermediate layer is of a photo-resist fluoro-polymer material secured to the top layer by ultraviolet (UV) curing and the bottom layer is a peel-off sheet of polyester film, secured to the intermediate layer by an adhesive. This allows the bottom layer to be subsequently peeled off and further experiments carried out. It also could allow the microchannel containing module to be cleaned and re-used.
The invention will be more clearly understood from the following description of some embodiments thereof, given by way of example only, with reference to the accompanying drawings, in which:
Referring to the drawings, and initially to
Referring now to
Since there are two reservoir well containing modules 16 in the embodiment described above, they are distinguished by the letters (a) and (b), the reservoir well containing module 16(a) being between the input module 15 and the microchannel containing module 17 and effectively forming input wells. Similarly, as described below, the reservoir well containing module 16(a) has three sets of wells 33, distinguished again by the letters (a), (b) and (c). Further, the wells 33 in the reservoir well containing modules 16(b) are identified by the reference letters (d), (e) and (f).
Referring now to
Referring to
The upper frame 13, illustrated in
Referring now to
Referring now to
Referring to
Also illustrated in
For completeness, it is necessary to describe briefly how an assay is carried out with the biochip assembly 1, such as, for example, for a cell adhesion study. Different ligands would be provided in each of two sets of the wells 33(a) and 33(b) of the reservoir containing module 16(a), namely the one closest to the input module 15. The ligands could, for example, be deposited there by pipetting or any suitable way. In some experiments, the number of transfer conduits 23 can be smaller than the microchannels in the microchannel containing module 17. For example, the same sample containing suspension cells could be placed in one of the wells 33(a), (b) or (c) of the reservoir well containing module 16(a). Typically, both the ligands and the sample liquids are placed in different sets of wells 33(a), (b) or (c), of the same reservoir well containing modules 16(a). To take the very simplest test and ignoring all operations such as flushing out of the system or using system liquid for propulsion, a cell adhesion test, in its simplest, can be described, for example, somewhat as follows. Two sample holder transfer assemblies 18 would normally be used simultaneously.
Step 1
A syringe pump or other suitable pumping means is connected to the inlet port 30.
Step 2
The sample holder transfer assembly 18 is connected between one of the wells, for example, the wells 33(a), containing a ligand which will have been pipetted or placed in it by any suitable means, and the output port 32 of the input module 15.
Step 3
The ligand is aspirated into the sample holder transfer assembly 18.
Step 4
The sample holder transfer assembly 18 is disconnected from the wells 33(a) and is connected to the input port 35 of the microchannel containing module 17.
Step 5
Ligand is then delivered into each microchannel 37 to coat the interior thereof.
Step 6
Replace the sample holder transfer assembly 18 or alternatively, clean it thoroughly.
Step 7
Connect to another set of the wells in the reservoir containing module 16, such as the wells 33(b), which contains a cell suspension.
Step 8
Aspirate the cell suspension.
Step 9
Disconnect the sample holder transfer assembly 18 from the wells 33(b) and connect to the input ports 35 of the microchannel containing module 17.
Step 10
Deliver the cell suspensions through the microchannels 37 and carry out the test.
The above is a very simple explanation, for example, almost certainly, an additional sample holder transfer assembly would be used to connect the outlet ports 36 of the microchannel containing module 17 with one of the sets of wells 33(d), 33(e) and 33(f) of the reservoir containing module 16(b). This would be used, for example, firstly to store any surplus ligand in one set of the wells 33(d), 33(e) or 33(f). Then, one of the remaining two sets of wells of 33(d), 33(e) and 33(f), would be used to store the cell suspension after the test.
It must be appreciated that the above is a very simplified and indeed, incomplete description of how a test is carried out. However, the actual manner in which a test is carried out is not important, it is the manner in which the sample holder transfer assembly 18 and the various other modules 15, 16 and 17 interact which is important.
Referring to
Referring to
It should be appreciated that the arrangements of
Referring now to
In one embodiment of the invention, the biochip modules is made of a mask of SU-8 photo-resist fluoro-polymer. This is used to form the intermediate layers 61 which is then sandwiched between the other two layers 60 and 62, followed by ultraviolet (UV) curing. Similar construction methods may be used to manufacture the input module 15 and the reservoir containing module 16.
Referring to
It will be appreciated that one of the easy ways, with these constructions of varying the cross sectional area of the microchannel 37, is simply to increase or decrease the width of the slot 64.
While the enclosed sample holder transfer assembly 18 has been described as incorporating flexible transfer conduits, these are not necessarily essential.
It will be appreciated that with the present constructions, various types of modules may be provided and while the sample holder transfer assembly that has been illustrated is a particularly useful assembly, it will be possible to provide other constructions without departing from the scope of the invention, as defined in the claims.
What has to be appreciated with the present invention is that by using the various modules, many sizes and shapes of microchannel, different arrangements of microchannel, different arrangements of reservoir wells, input modules and indeed, sample holder transfer assemblies, may be used. For example, the separation between the reservoir wells is ideally such that it matches one of the standard values of separations between wells in a conventional microtiter plate which is generally 9 mm or fractions thereof. Needless to say, other values of separation are possible and any numbers may be provided. Indeed, it will be appreciated that microchannel containing modules may be provided in various shapes and sizes to suit the particular type of test required.
While the present invention has been described for use with tests involving cells, it will be appreciated that various other tests may also be provided where such tests should be carried out in microchannels. Indeed, any non-cell based assay may also be carried out with the present biochip assembly.
It will be appreciated that various methods may be provided for cleaning the sample holder transfer assembly and the parts thereof. For example, the assembly may simply be removed and disposed of after being used, to aspirate and deliver any one liquid, whether it be a reaction liquid, a cell-based liquid or a ligand. Needless to say, they can be relatively easily cleaned. Further, flushing out, using a system liquid, may also be achieved.
It will be appreciated, as in the embodiments described above, and in particular those illustrated, the length of the microchannels have been greatly foreshortened. However, it will be appreciated that the microchannels can be lengthened by intertwining the microchannels, as shown, for example, in one embodiment. Indeed, any length of microchannel or indeed, any shape or cross-sectional shape of microchannel may be provided.
It should also be appreciated that one of the major advantages of the biochip assembly according to the present invention, is that the biochip can be easily integrated into other laboratory instruments. For example, they can be easily fitted into a micro plate reader which adds significant advantages over currently existing systems.
One of the major advantages of the biochip assembly, in accordance with the present invention, is the reduction in reagent or sample consumption. It will also facilitate reduced analysis time and larger transfer rates, due to the diminished distances involved. Further, it will be appreciated that the biochip assembly will facilitate the running of several assays in parallel.
It will also be appreciated that the use of plastics materials reduces significantly the cost of production.
In the specification the terms “comprise, comprises, comprised and comprising” or any variation thereof and the terms “include, includes, included and including” or any variation thereof are considered to be totally interchangeable and they should all be afforded the widest possible interpretation and vice versa.
The invention is not limited to the embodiment hereinbefore described, but may be varied in both construction and detail within the scope of the claims.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IE03/00166 | 12/10/2003 | WO | 00 | 6/18/2007 |